XML 44 R32.htm IDEA: XBRL DOCUMENT v3.5.0.2
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details Narrative)
9 Months Ended
Sep. 30, 2016
USD ($)
Number
Dec. 31, 2015
USD ($)
Shelf life of prescription products 24 months  
Number of operating segment | Number 1  
Related to Research and Development Activities [Member]    
Advance payments - total $ 244,335 $ 1,138,073
Advance payments - other assets current   1,009,175
Advance payments - long term prepaid expense   $ 128,898
Minimum [Member]    
Return period of unsalable prescription products 6 months  
Maximum [Member]    
Return period of unsalable prescription products 12 months